Interested in becoming a principal researcher? Read this first.
Mark Packer, MD, FACS, CPI
Advertisement
Articles by Mark Packer, MD, FACS, CPI
Rho kinase inhibitors are intriguing in that they work directly on the pathogenic mechanism of abnormally elevated IOP, increased resistance to trabecular outflow.
Advertisement
Latest Updated Articles
- Pearls and pitfalls for principal investigators
March 8th 2018
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA guidance to help accelerate cell and gene therapies
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
The Residency Report: Cardiovascular risk scores as a window into ocular disease
4
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
5